Once you’ve moved into Phase II, the likelihood that your drug will be approved begins to increase substantially. Because of this, it’s a vital time to start investing resources in your go to market strategy. Hence, at Phase II we begin to dig deeper into our research, focusing on what’s going to be needed to launch and sell the new drug, as well as beginning to plan pricing and market access strategies.

At Two Labs, we have a vast network of key opinion leaders, including MDs, academics, nurses, pharmacists, and sales experts, which we can leverage to give you the insight needed to move forward with confidence.